#personalized healthcare

Discover 2 curated intelligence briefings related to this specific topic.

The Death of the Average: How Longitudinal Data is Dismantling the Medical Guideline
Health & Medicine

The Death of the Average: How Longitudinal Data is Dismantling the Medical Guideline

For decades, medicine relied on the 'average patient' to set guidelines. Now, a surge in longitudinal health tracking is rendering those averages obsolete, shifting the focus toward individual baselines and predictive, personalized interventions.

Read Analysis
The End of the Average: Why N-of-1 Trials are the New Gold Standard
Health & Medicine

The End of the Average: Why N-of-1 Trials are the New Gold Standard

For decades, medicine has relied on the Randomized Controlled Trial to determine what works. But the average patient is a statistical ghost. We are witnessing a systemic pivot toward N-of-1 trials, where the individual becomes their own control, dismantling the 20th-century obsession with population-level data.

Read Analysis